-
Company Insights
NewElevance Health – Digital Transformation Strategies
Elevance Health Digital Transformation Strategies Overview Elevance Health is tapping the power of big data analytics to analyze data and generate insights, improve member engagement, and detect fraudulent claims. AI, big data, cloud, and automation are among the key technologies under focus for the company. The annual ICT spending of Elevance Health was estimated at $3.8 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Elevance Health Inc...
-
Innovation Ranking
NewInnovation Ranking – Hyundai Elevator Co Ltd
Hyundai Elevator Co Ltd (Hyundai Elevator) carries out the business of producing a range of vertical and horizontal transportation systems. It offers products such as elevators, marine elevators, escalators, and parking systems. The company's elevators range includes passenger elevators, observation elevators, hospital elevators, automobile elevators and freight elevators. Hyundai Elevator also provides Hyundai Integrated Parking (HIP) system, cart type parking system. It offers services such as Hyundai Real Time Services (HRTS), maintenance, installation services and Hyundai Customer Care Center (HCCC)....
-
Product Insights
Elevation Solar PV Park
Elevation Solar PV Park is a solar PV project located in California, United States. The project is owned by Alberta Investment Management Corp; StepStone Group LP; The AES Corp; ULLICO Inc and was developed by Sustainable Power Group LLC. The project came online in 2016. Empower your strategies with our Elevation Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...
-
Product Insights
NewNet Present Value Model: Elevation Oncology Inc’s Seribantumab
Empower your strategies with our Net Present Value Model: Elevation Oncology Inc's Seribantumab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Analyst Opinions
NewCocktail Culture – Industry Insights, Consumer Drivers, Brand Challenges and Innovation Landscape
In 2024, cocktail culture has been influenced by relatively recent developments-the craft craze, COVID's elevation of home-based indulgence and entertaining, increased RTD product diversity and sophistication, and the emergence of a more experiential, quality- not quantity-focused Generation Z consumer base-contributing to a further potential growth in relevance relative to other forms of alcohol, particularly in the premium indulgence space. So-called cocktail culture is a historic trend that has undergone several movements over more than 200 years. In the 21st century,...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperphenylalaninemia
Overview How likely is it that the drugs in Hyperphenylalaninemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperphenylalaninemia Overview Abnormally elevated levels of phenylalanine (PHE) in the blood if >2mg/dl...
-
Product Insights
NewLikelihood of Approval Analysis for Polymyalgia Rheumatica (PMR)
Overview How likely is it that the drugs in Polymyalgia Rheumatica (PMR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polymyalgia Rheumatica (PMR) Overview Polymyalgia rheumatica (PMR) is a rheumatic disorder...
-
Company Insights
Innovation and Patenting activity of Elevance Health Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Elevance Health Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval Analysis for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Overview How likely is it that the drugs in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Overview Waldenstrom macroglobulinemia, one of the...